Skip to main content

Amgen news and events in 2026

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today.

Public (AMGN)Biotechnology Research10,000+ employeesamgen.comLinkedIn

Dated updates
80
Last event
Sep 29, 2026
Open rolesSnapshot Sep 29, 2026
224
Latest SEC filing
Aug 4, 2026

Overview

Amgen by topic

Latest events

Latest Amgen events

  1. In development
    Sjögren's Syndrome Market to Witness Sustained Growth During the Forecast Period (2026-2036) Due to the Development of Targeted Immunotherapies, FcRn Inhibitors, TYK2...Amgen is developing Dazodalibep, an investigational biologic targeting the CD40-CD40L pathway for Sjögren's disease.
  2. Integration
  3. In development
    Cholesterol drug setback casts doubt over multibillion-dollar raceAmgen is developing a drug, olpasiran, to lower Lp(a) cholesterol as a rival treatment to Novartis's pelacarsen.
  4. Partnership
  5. In development
  6. Revenue
    Global DLL3 Targeted Therapies Market 2026-2030: Profiles Amgen, Zai Lab, Boehringer Ingelheim and Phanes TherapeuticsAmgen's product Imdelltra reported revenue of more than USD 600 million in 2025.
  7. New location
    Amgen (AMGN) Opens New Science And Innovation Center In HyderabadAmgen has opened a new Science and Innovation Center in Genome Valley, Hyderabad, to expand its global research and development presence.
  8. Revenue
    AMGEN REPORTS SECOND QUARTER 2026 FINANCIAL RESULTSAmgen reported total product sales of $9.537 billion for the second quarter of 2026, a 9% increase year-over-year.
  9. Partnership
    Amgen (AMGN) Partners With MrBeast To Fund Pediatric Cancer Research And Reach 500 Million SubscribersAmgen has partnered with YouTube personality MrBeast on a video campaign to raise awareness and funding for pediatric cancer research.
  10. In development

Showing 10 of 24 events. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Amgen with the Signal API

One POST /v1/companies/enrich call with amgen.com returns every signal type for Amgen, each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"amgen.com","limit":20}'

Same industry

Amgen questions

What is the latest news on Amgen?
On Sep 16, 2026, prnewswire.com reported: Sjögren's Syndrome Market to Witness Sustained Growth During the Forecast Period (2026-2036) Due to the Development of Targeted Immunotherapies, FcRn Inhibitors, TYK2. This page tracks 24 news events for Amgen since Oct 5, 2025, each with a date and a source link.
What is going on with Amgen?
In the 90 days to Sep 30, 2026, Autobound tracked 10 news events, 1 10-Q filing, 1 8-K filing, 4 hiring snapshots, 24 signals for Amgen. The newest story is from Sep 16, 2026 (In development), reported by prnewswire.com.
What else does Autobound track for Amgen?
Beyond news and filings, Autobound lists 45+ signals for Amgen from 4 sources: Glassdoor (15+), LinkedIn (15+), Patents (12), Reddit (3). See the Amgen signals page for the dated list.
Is Amgen hiring right now?
Yes. As of Sep 29, 2026, Amgen had 224 open roles, and Engineering had the most with 26.

Source. News, SEC filings (8-K, 10-K, 10-Q, Form D), hiring data and other signals (Reddit, podcasts, Glassdoor, reviews, social posts, patents, web traffic) from the Autobound Signal API.

Method. Stories are grouped when they report the same event within 14 days. Rows that do not name the company are removed. Each row links its source.

Data as of .

How this data is built →Get it from the Signal API →